Dr. Nicolas Mercure-Corriveau – Oncologist / Hematologist | Montréal, QC

Dr. Nicolas Mercure-Corriveau is a Hematologist focused on diagnosing and managing a spectrum of blood disorders, from anemias and clotting issues to blood cancers. Practicing at CHUM, Hématologie in Montréal, QC, he is part of a dedicated healthcare team. His practice is grounded in the standards set by the Collège des médecins du Québec (CMQ), ensuring high-quality, safe, and ethical care. Dr. Mercure-Corriveau addresses a wide array of benign and malignant hematologic disorders, offering both diagnostic expertise and therapeutic interventions. His approach is patient-centered, emphasizing hope, clarity, and support throughout the treatment journey. The care he provides is tailored to adults with suspected or diagnosed cancer and blood disorders, with access to advanced diagnostic tools and treatment options that foster positive outcomes.

He graduated with a Medical Degree in 2020 and has been practicing as a Hematologist for over four years, since 2020. His extensive post-graduate medical training and certification in Hematology (Blood Disorders) underpin his clinical expertise. Dr. Mercure-Corriveau continuously updates his knowledge to incorporate the latest advancements in blood disorder diagnosis and treatment, ensuring patients benefit from evidence-based and innovative care strategies.

Driven by a commitment to multidisciplinary collaboration, Dr. Mercure-Corriveau integrates research, clinical excellence, and compassionate patient support. He dedicates himself to providing personalized care in Montréal, speaking French fluently to better serve his community. His philosophy centers on empowering patients and their families, fostering hope, and advancing the field of hematology through ongoing learning and compassionate practice.

Dr. Nicolas Mercure-Corriveau has expertise in managing a wide range of conditions, including:

Hematologic Malignancies (Blood Cancers) Treated

• Myeloproliferative Neoplasms (MPN) (Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis): A group of chronic blood cancers where the bone marrow produces too many red blood cells, white blood cells, or platelets.
• Acute Myeloid Leukemia (AML): A rapidly progressing cancer of the blood and bone marrow affecting myeloid cells.
• Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL): A type of cancer that starts from white blood cells (lymphocytes) in the bone marrow, typically slow-growing.

Benign Hematologic (Non-Cancerous Blood) Disorders Managed

• Hereditary Hemochromatosis & Other Iron Overload States: Genetic or acquired conditions leading to excessive iron accumulation in the body, requiring management to prevent organ damage.
• Sickle Cell Disease & Thalassemia Syndromes: Inherited disorders affecting the structure or production of hemoglobin, leading to various complications.
• Aplastic Anemia & Bone Marrow Failure Syndromes: Rare but serious conditions where the bone marrow doesn't produce enough new blood cells.

This list provides examples of common conditions treated and is not exhaustive. Cancer and blood disorders are complex, and treatment is highly individualized. For personalized advice, please discuss your specific situation with Dr. Nicolas Mercure-Corriveau or your referring physician.

• Therapeutic Apheresis Consultation (e.g., for TTP, plasma exchange indications): Consultation and coordination for procedures that separate components of blood for therapeutic purposes.
• Performance Status Assessment & Treatment Eligibility Evaluation: Evaluating a patient's overall fitness and ability to tolerate specific anti-cancer treatments.
• Immune Thrombocytopenia (ITP) & Other Platelet Disorders Management: Investigating and managing low platelet counts due to immune or other causes.
• Diagnosis & Multimodal Management of Leukemias (AML, ALL, CLL, CML, Hairy Cell): Comprehensive care for various types of leukemia, including diagnostic workup (bone marrow interpretation, cytogenetics, molecular testing), chemotherapy, targeted therapy, and coordination for stem cell transplant where indicated.
• Interpretation of Special Hematologic Tests (e.g., Flow Cytometry, Cytogenetics, Molecular Studies): Analyzing results from advanced laboratory tests crucial for diagnosing and classifying hematologic conditions.
• Neutropenia & Other White Blood Cell Disorders Evaluation: Investigating and managing low or abnormal white blood cell counts, increasing susceptibility to infections.
• Management of Myelodysplastic Syndromes (MDS): Diagnosis and treatment of bone marrow failure disorders, including supportive care, growth factors, and disease-modifying therapies.

Note: This list provides a general overview of services offered in Hematology (Blood Disorders). Treatment plans are highly individualized. Dr. Mercure-Corriveau provides a wide array of diagnostic, therapeutic, and supportive care options tailored to each patient's specific condition and needs. Please discuss with Dr. Mercure-Corriveau or your healthcare team for details relevant to your care.

All medical services and treatments are provided in accordance with the standards of practice set by the Collège des médecins du Québec (CMQ) and relevant cancer care guidelines. A referral is required.

Dr. Mercure-Corriveau practices primarily at CHUM, Hématologie, situated in the vibrant Ville-Marie East (Quartier Latin, Village) neighborhood of Montréal. The clinic is conveniently accessible from the Pont Jacques-Cartier Access and Major North-South Arterial, making it easy for patients traveling from various parts of the city. Public transit options are plentiful, with the Société de transport de Montréal (STM) providing accessible services via Métro and Bus routes. The facility itself is wheelchair accessible to accommodate all patients comfortably. Paid parking options are close by, ensuring convenient access for those arriving by car. This central location offers a welcoming environment dedicated to comprehensive blood disorder care, emphasizing patient comfort and accessibility.

Are consultations and treatments with Dr. Mercure-Corriveau, an Hematologist, covered by Régie de l'assurance maladie du Québec (RAMQ) in QC?

Medically necessary consultations, diagnostic tests (like biopsies, imaging reviews), chemotherapy, immunotherapy, targeted therapies, radiation therapy planning and delivery, and management of blood disorders by a licensed Hematologist such as Dr. Mercure-Corriveau are generally covered by Régie de l'assurance maladie du Québec (RAMQ) in QC when a referral from a family doctor or another specialist is in place. Specific drug coverage for newer therapies can vary by provincial formularies and may require special authorization. It's always recommended to discuss coverage specifics with Régie de l'assurance maladie du Québec (RAMQ), Dr. Mercure-Corriveau's office, the hospital's patient financial services, or the cancer care navigation services at the treatment facility.

Do I need a referral to see Dr. Mercure-Corriveau, an Hematologist?

Yes, a referral from your family physician or another specialist is almost always required to see an Hematologist like Dr. Mercure-Corriveau for assessment or treatment of cancer or significant hematological conditions. This ensures that your primary care provider is involved in your care continuum and that you are directed to the most appropriate specialist for your specific situation. Cancer care programs often have centralized intake systems that manage referrals to ensure timely access.

Why might I need a bone marrow biopsy, and what does it involve if Dr. Mercure-Corriveau recommends it?

A bone marrow biopsy and aspiration are procedures used to collect and examine bone marrow, the soft tissue inside your bones where blood cells are made. Dr. Mercure-Corriveau might recommend this test to diagnose or monitor various blood disorders, including leukemias, lymphomas, myeloma, anemias, or infections. The procedure is usually done on the back of the hip bone under local anesthesia. A needle is used to withdraw a small sample of liquid marrow (aspiration) and a small core of bone marrow tissue (biopsy). You may feel some pressure or brief pain.

What can I expect at my first appointment with an Oncologist/Hematologist?

Your first appointment with Dr. Mercure-Corriveau will be comprehensive and may last an hour or more. It will involve a detailed review of your medical history, family history of cancer, current symptoms, medications, and any previous tests, imaging results (CT, MRI, PET scans), and biopsy reports related to your diagnosis. He will likely perform a thorough physical examination. The main goals are to confirm your diagnosis, discuss the type and stage of your condition (if applicable), and outline potential treatment options. This is a crucial time to ask questions, and you are encouraged to bring a family member or friend for support and to help take notes. Dr. Mercure-Corriveau will explain the proposed treatment plan, including goals, benefits, potential side effects, duration, and what to expect moving forward. Further tests may be ordered.

What is targeted therapy in cancer treatment?

Targeted therapy uses drugs or other substances to identify and attack specific types of cancer cells with less harm to normal cells. These therapies work by targeting specific genes or proteins found in cancer cells or cells related to cancer growth, like blood vessel cells. Genetic testing of the tumor is often done to see if a targeted therapy is likely to be effective. Dr. Mercure-Corriveau can explain if targeted therapy is an option for your cancer.

CHUM, Hématologie
1000 rue Saint-Denis
Montréal, QC H2X 0C1

Phone: (514) 890-8000

The facility is wheelchair accessible.

Dr. Mercure-Corriveau is a licensed Hematologist regulated by the Collège des médecins du Québec (CMQ) under the Medical Act in QC. A referral from a family physician or other specialist is required for most consultations and treatments under the provincial health plan.

Verify registration with the Collège des médecins du Québec (CMQ): https://www.cmq.org/en/directory/physicians?number=20247